| Product Name |
Fulvestrant EP Impurity D |
| Product Category | Impurities, Intermediates |
| Sub-Category | Sulphur and Selenium Compounds, Pharmaceutical Standards, Fine Chemicals, Steroids, Chiral Standards |
| CAS No | N/A |
| Catalog Number | GS.47.FUL.04 |
| Chemical Name/Synonyms | 7ξ,7'ξ-nonane-1,9-diyldi(estra-1,3,5(10)-triene-3,17β-diol); (8R,9S,13S,14S,17S)-7-(9-((8R,9S,13S,14S,17R)-3,17-Dihydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-7-yl)nonyl)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol; (8R,8'R,9S,9'S,13S,13'S,14S,14'S,17S,17'S)-7,7'-(Nonane-1,9-diyl)bis(13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol); Fulvestrant sterol dimer; 7α,7α-Nonamethylenebis[estra-1,3,5(10)-triene-3,17β-diol] (USP); |
| Molecular Weight | 668.99 |
| Molecular Formula | C45H64O4 |
| Purity | NLT 95 % |
| Applications | Fulvestrant EP Impurity D is an impurity of Fulvestrant, which is an estrogen receptor antagonist used as a medication indicated for the treatment of hormone receptor (HR)-positive metastatic breast cancer in postmenopausal women. |
| Inventory Status | customized |